Metis Global Partners LLC Buys 11,363 Shares of Healthpeak Properties, Inc. (NYSE:DOC)

Metis Global Partners LLC lifted its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 6.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 186,503 shares of the real estate investment trust’s stock after purchasing an additional 11,363 shares during the period. Metis Global Partners LLC’s holdings in Healthpeak Properties were worth $3,780,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. HM Payson & Co. bought a new stake in shares of Healthpeak Properties during the 3rd quarter worth approximately $25,000. Avior Wealth Management LLC bought a new stake in shares of Healthpeak Properties during the 3rd quarter worth approximately $37,000. Groupama Asset Managment bought a new stake in shares of Healthpeak Properties during the 3rd quarter worth approximately $37,000. Capital Performance Advisors LLP bought a new stake in shares of Healthpeak Properties during the 3rd quarter worth approximately $42,000. Finally, Wiser Advisor Group LLC bought a new stake in Healthpeak Properties in the 3rd quarter valued at $42,000. Institutional investors own 93.57% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the company. Morgan Stanley upgraded Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price target on the stock in a research note on Wednesday, January 15th. Robert W. Baird dropped their price target on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a research note on Tuesday, February 11th. Wells Fargo & Company dropped their price target on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating on the stock in a research note on Tuesday, December 10th. Scotiabank dropped their price target on Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating on the stock in a research note on Friday. Finally, Royal Bank of Canada increased their price target on Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $23.92.

Healthpeak Properties Stock Performance

DOC opened at $20.44 on Friday. The firm has a market cap of $14.30 billion, a P/E ratio of 58.39, a price-to-earnings-growth ratio of 2.17 and a beta of 1.15. Healthpeak Properties, Inc. has a 52-week low of $16.49 and a 52-week high of $23.26. The company has a debt-to-equity ratio of 0.96, a quick ratio of 1.35 and a current ratio of 1.35. The business’s fifty day moving average is $20.19 and its 200-day moving average is $21.35.

Healthpeak Properties Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, February 26th. Stockholders of record on Friday, February 14th were issued a dividend of $0.305 per share. This is a positive change from Healthpeak Properties’s previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a dividend yield of 5.97%. The ex-dividend date was Friday, February 14th. Healthpeak Properties’s dividend payout ratio is 348.57%.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.